WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2016065236) CARBAZOLE DERIVATIVES
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2016/065236 International Application No.: PCT/US2015/057077
Publication Date: 28.04.2016 International Filing Date: 23.10.2015
IPC:
C07D 401/04 (2006.01) ,C07D 403/04 (2006.01) ,C07D 471/04 (2006.01) ,C07D 209/88 (2006.01) ,A61K 31/403 (2006.01) ,A61P 29/00 (2006.01) ,A61P 37/00 (2006.01)
Applicants: BRISTOL-MYERS SQUIBB COMPANY[US/US]; Route 206 and Province Line Road Princeton, New Jersey 08543, US
Inventors: AHMAD, Saleem; US
BATT, Douglas G.; US
LIU, Qingjie; US
MACOR, John E.; US
TINO, Joseph A.; US
WATTERSON, Scott Hunter; US
NAIR, Satheesh Kesavan; IN
MAISHAL, Tarun Kumar; IN
Agent: GREENBLATT, Gary D.; US
Priority Data:
62/068,23424.10.2014US
Title (EN) CARBAZOLE DERIVATIVES
(FR) DÉRIVÉS DE CARBAZOLE
Abstract: front page image
(EN) Disclosed are compounds of Formula (I): (I) or a salt thereof, wherein Q, R1a, R1b, R2a, R2b, R3, R4, R5a, R5b, R6a, R6c, R7a, R7b, R7c, and R7d are defined herein. Also disclosed are methods of using such compounds as inhibitors of Bruton's tyrosine kinase (Btk), and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.
(FR) L'invention concerne des composés de formule (I), ou un sel de ces composés, R1a, R1b, R2a, R2b, R3, R4, R5a, R5b, R6a, R6c, R7a, R7b, R7c et R7d étant tels que définis dans la description. L'invention concerne également des procédés d'utilisation de ces composés comme inhibiteurs de la tyrosine kinase de Bruton (Btk), ainsi que des compositions pharmaceutiques comprenant ces composés. Ces composés sont utiles dans le traitement, la prévention ou le ralentissement de la progression de maladies ou de troubles dans une diversité de domaines thérapeutiques, tels que les maladies auto-immunes et les maladies vasculaires.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)